NEW YORK, July 6, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:

Growth Hormone Deficiency Global Clinical Trials Review, Q2,
2011

http://www.reportlinker.com/p0567405/Growth-Hormone-Deficiency-Global-Clinical-Trials-Review-Q2-2011.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Growth Hormone Deficiency Global Clinical Trials Review, Q2,
2011

Summary

GlobalData’s clinical trial report, “Growth Hormone Deficiency
Global Clinical Trials Review, Q2, 2011” provides data on the
Growth Hormone Deficiency clinical trial scenario. This report
provides elemental information and data relating to the clinical
trials on Growth Hormone Deficiency. It includes an overview of the
trial numbers and their recruitment status as per the site of trial
conduction across the globe. The databook offers a preliminary
coverage of disease clinical trials by their phase, trial status,
prominence of the sponsors and also provides briefing pertaining to
the number of trials for the key drugs for treating Growth Hormone
Deficiency. This report is built using data and information sourced
from proprietary databases, primary and secondary research and
in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered
based on the availability and relevance of data for the indicated
disease.

Scope

– Data on the number of clinical trials conducted in North
America, South and Central America, Europe, Middle-East and Africa
and Asia-pacific and

‘/>”/>

SOURCE